se of Halometasone in skin diseases caused by occupational exposure to different agents.

Phase 4

Completed

• Conditions: Health Condition 1: null- Occupational contact dermatitis (both irritant and allergic)

• Registration Number: CTRI/2014/08/004876
• Lead Sponsor: SELF

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 150

Inclusion Criteria

•All patients with pruritic eczematous conditions that started or aggravated for the first time after joining the present occupation will be included. The diagnosis of occupational contact dermatitis will be done based on taking detailed medical and occupational history and the presence of clinical signs and symptoms including pruritus and eczema.

•Lesions over all areas, including exposed as well as covered areas, will be included unless they are solely restricted to covered areas/ groins or genitalia.

Exclusion Criteria

•The diseases excluded were infective diseases like scabies, fungal infections, bacterial infections and all noneczematous dermatoses like psoriasis and lichen planus, even if associated with itching.

•Lesions solely affecting the groins, genitals or covered areas.

•Patients who are already under treatment for the presenting conditions.

•Patients with history of hypersensitivity to topical steroids.

•Patients (including severe/extensive eczema) in need of any form of treatment that influences the healing of the lesion such as topical treatment other than trial preparation, topical radiation therapy, systemic medication with antibiotics, antimicrobials, antihistaminics, cytostatics, corticosteroids, or ACTH will also be excluded.

•Pregnant and nursing women, patients with history of cardiovascular, hematological, pancreatic, metabolic, neurological, or clinically significant laboratory abnormalities which would interfere with patient participation in the study or evaluation of patientâ??s response to therapy were excluded from screening.

Study & Design

• Study Type: Interventional
• Study Design: Not specified